Zhiqun Xie
6PUBLICATIONS
20CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Sep 06, 2022
Ectopic JAK-STAT activation enables the transition to a stem-like and multilineage state conferring AR-targeted therapy resistance.Su Deng, Choushi Wang, Yunguan Wang
|Oct 05, 2021
Determinants of renal cell carcinoma invasion and metastatic competence.Kangsan Kim, Qinbo Zhou, Alana Christie
|Feb 23, 2020
Tumor neoantigenicity assessment with CSiN score incorporates clonality and immunogenicity to predict immunotherapy outcomes.Tianshi Lu, Shidan Wang, Lin Xu
|Nov 16, 2019
HIF-2 Complex Dissociation, Target Inhibition, and Acquired Resistance with PT2385, a First-in-Class HIF-2 Inhibitor, in Patients with Clear Cell Renal Cell Carcinoma.Kevin D Courtney, Yuanqing Ma, Alberto Diaz de Leon
|Jun 10, 2018
An Empirical Approach Leveraging Tumorgrafts to Dissect the Tumor Microenvironment in Renal Cell Carcinoma Identifies Missing Link to Prognostic Inflammatory Factors.Tao Wang, Rong Lu, Payal Kapur
Pageof 1
Frequent Collaborators
4 joint publications
Tao Wang
2 joint publications
Douglas Strand
2 joint publications
Ping Mu
2 joint publications
Bo Li
2 joint publications
Donald J Vander Griend
2 joint publications
Ganesh Raj
2 joint publications
Xihui Liu
2 joint publications
Choushi Wang
1 joint publications
Yin Xi
1 joint publications
Jianjun Gao
